• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Lagevrio

coronavirus Omicron
Posted inCOVID-19, Infections, Research

Omicron Treatment: Most Effective Drugs

August 31, 2022September 8, 2022

Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.

Molnupiravir
Posted inCOVID-19, Infections, New Drugs, Regulatory

Molnupiravir Approved in the U.S.

December 23, 2021September 8, 2022

An oral antiviral drug by Merck & Co. has joined the armamentarium of the pharmacological fight against COVID-19.

Molnupiravir: New Effective Pill for Coronavirus. All That We Know
Posted inClinical Trials, COVID-19, Infections

Molnupiravir: New Effective Pill for Coronavirus. All That We Know

December 14, 2021September 8, 2022

Molnupiravir pills by Merck & Co. can help COVID-19 patients avoid going to the hospital or dying.

Molnupiravir: What U.S. Experts Said
Posted inCOVID-19, Infections, Regulatory

Molnupiravir: What U.S. Experts Said

December 1, 2021September 8, 2022

FDA scientists took a detailed look at molnupiravir for treating COVID-19.

molnupiravir
Posted inCOVID-19, Infections, New Drugs, Regulatory

Lagevrio: New Antiviral Drug to Treat COVID-19

November 4, 2021September 8, 2022

The oral antiviral drug molnupiravir by Merck & Co.

BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News